Papers authored by Durando X

Collect these papers and discover other ones on Labmeeting. Learn more.
Loss of Bcl-2 expression in colon cancer: a prognostic factor for recurrence in stage II colon cancer.
+ cite this
+ View Abstract
Poincloux L, Durando X, Seitz JF, Thivat E, Bardou VJ, Giovannini MH, Parriaux D, Barriere N, Giovannini M, Delpero JR, and Monges G
Surgical oncology 18(4):357-65, 2009 Dec - Who cited this? | PubMed ID: 19027288 | Fulltext
Recommend
Clinicopathological factors and nomograms predicting nonsentinel lymph node metastases after neoadjuvant chemotherapy in breast cancer patients.
+ cite this
+ View Abstract
Gimbergues P, Abrial C, Durando X, Le Bouedec G, Cachin F, Penault-Llorca F, Mouret-Reynier MA, Kwiatkowski F, Maublant J, Tchirkov A, and Dauplat J
Annals of surgical oncology 16(7):1946-51, 2009 Jul - Who cited this? | PubMed ID: 19408057 | Fulltext
Recommend
Comparative review of anastrozole, letrozole and exemestane in the management of early breast cancer.
+ cite this
+ View Abstract
Nabholtz JM, Mouret-Reynier MA, Durando X, Van Praagh I, Al-Sukhun S, Ferriere JP, and Chollet P
Expert opinion on pharmacotherapy 10(9):1435-47, 2009 Jun - Who cited this? | PubMed ID: 19445563 | Fulltext
Recommend
Metastatic breast cancer: overall survival related to successive chemotherapies. What do we gain after the third line?.
+ cite this
+ View Abstract
Tacca O, Leheurteur M, Durando X, Mouret-Reynier MA, Abrial C, Thivat E, Bayet-Robert M, Penault-Llorca F, and Chollet P
Cancer investigation 27(1):81-5, 2009 Jan - Who cited this? | PubMed ID: 19191099 | Fulltext
Recommend
O-Mel-Inib: A Cancéro-pôle Nord-Ouest multicenter phase II trial of high-dose Imatinib mesylate in metastatic uveal melanoma.
+ cite this
+ View Abstract
Penel N, Delcambre C, Durando X, Clisant S, Hebbar M, Negrier S, Fournier C, Isambert N, Mascarelli F, and Mouriaux F
Investigational new drugs 26(6):561-5, 2008 Dec - Who cited this? | PubMed ID: 18551246 | Fulltext
Recommend
Changes and Predictive and Prognostic Value of the Mitotic Index, Ki-67, Cyclin D1, and Cyclo-oxygenase-2 in 710 Operable Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
+ cite this
+ View Abstract
Penault-Llorca F, Abrial C, Raoelfils I, Chollet P, Cayre A, Mouret-Reynier MA, Thivat E, Mishellany F, Gimbergues P, and Durando X
The oncologist 13(12):1235-45, 2008 Dec - Who cited this? | PubMed ID: 19091781 | Fulltext
Recommend
Measurement of residual disease after neoadjuvant chemotherapy.
+ cite this
Abrial C, Thivat E, Tacca O, Durando X, Mouret-Reynier MA, Gimbergues P, Penault-Llorca F, and Chollet P
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 26(18):3094; author reply 3095, 2008 Jun 20 - Who cited this? | PubMed ID: 18565900 | Fulltext
Recommend
Comparison of the prognostic significance of Chevallier and Sataloff's pathologic classifications after neoadjuvant chemotherapy of operable breast cancer.
+ cite this
+ View Abstract
Penault-Llorca F, Abrial C, Raoelfils I, Cayre A, Mouret-Reynier MA, Leheurteur M, Durando X, Achard JL, Gimbergues P, and Chollet P
Human pathology, 2008 Jun 9 - Who cited this? | PubMed ID: 18547616 | Fulltext
Recommend
Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation.
+ cite this
+ View Abstract
Gimbergues P, Abrial C, Durando X, Bouedec GL, Cachin F, Penault-Llorca F, Mouret-Reynier MA, Kwiatkowski F, Maublant J, Tchirkov A, and Dauplat J
Annals of surgical oncology 15(5):1316-21, 2008 May - Who cited this? | PubMed ID: 18311507 | Fulltext
Recommend
A new prognostic classification after primary chemotherapy for breast cancer: residual disease in breast and nodes (RDBN).
+ cite this
+ View Abstract
Chollet P, Abrial C, Durando X, Thivat E, Tacca O, Mouret-Reynier MA, Leheurteur M, Kwiatkowski F, Dauplat J, and Penault-Llorc F
Cancer journal (Sudbury, Mass.) 14(2):128 - Who cited this? | PubMed ID: 18391619 | Fulltext
Recommend
[Methionine dependency of cancer cells: a new therapeutic approach?].
+ cite this
+ View Abstract
Durando X, Thivat E, Gimbergues P, Cellarier E, Abrial C, Dib M, Tacca O, and Chollet P
Bulletin du cancer 95(1):69-76, 2008 Jan 1 - Who cited this? | PubMed ID: 18230572 | Fulltext
Recommend
Optimal methionine-free diet duration for nitrourea treatment: a phase I clinical trial.
+ cite this
+ View Abstract
Durando X, Thivat E, Farges MC, Cellarier E, D'Incan M, Demidem A, Vasson MP, Barthomeuf C, and Chollet P
Nutrition and cancer 60(1):23-30, 2008 - Who cited this? | PubMed ID: 18444132 | Fulltext
Recommend
Temozolomide treatment of an adult with a relapsing medulloblastoma.
+ cite this
+ View Abstract
Durando X, Thivat E, Gilliot O, Irthum B, Verrelle P, Vincent C, and Bay JO
Cancer investigation 25(6):470-5, 2007 Sep - Who cited this? | PubMed ID: 17882660 | Fulltext
Recommend
Changes in and prognostic value of hormone receptor status in a series of operable breast cancer patients treated with neoadjuvant chemotherapy.
+ cite this
+ View Abstract
Tacca O, Penault-Llorca F, Abrial C, Mouret-Reynier MA, Raoelfils I, Durando X, Achard JL, Gimbergues P, Curé H, and Chollet P
The oncologist 12(6):636-43, 2007 Jun - Who cited this? | PubMed ID: 17602055 | Fulltext
Recommend
Achieving higher pathological complete response rates in HER-2-positive patients with induction chemotherapy without trastuzumab in operable breast cancer.
+ cite this
+ View Abstract
Penault-Llorca F, Abrial C, Mouret-Reynier MA, Raoelfils I, Durando X, Leheurteur M, Gimbergues P, Tortochaux J, Curé H, and Chollet P
The oncologist 12(4):390, 2007 Apr - Who cited this? | PubMed ID: 17470681 | Fulltext
Recommend
Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category.
+ cite this
+ View Abstract
Gimbergues P, Dauplat MM, Cayre A, Durando X, Le Bouedec G, Finat-Duclos F, Portefaix G, Kwiatkowski F, Dauplat J, Penault-Llorca F, and Tchirkov A
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 33(1):16-22, 2007 Feb - Who cited this? | PubMed ID: 17071045 | Fulltext
Recommend
A methionine-free diet associated with nitrosourea treatment down-regulates methylguanine-DNA methyl transferase activity in patients with metastatic cancer.
+ cite this
+ View Abstract
Thivat E, Durando X, Demidem A, Farges MC, Rapp M, Cellarier E, Guenin S, D'Incan M, Vasson MP, and Chollet P
Anticancer research 27(4C):2779-83, 2007 - Who cited this? | PubMed ID: 17695447 | Fulltext
Recommend
[Indications, contra-indications, expected results and choice of neoadjuvant chemotherapy for operable breast cancer].
+ cite this
+ View Abstract
Mouret-Reynier MA, Abrial C, Leheurteur M, Durando X, Van Praagh I, Gimbergues P, Achard JL, Ferrière JP, Cure H, and Chollet P
Bulletin du cancer 93(11):1121-9, 2006 Nov 1 - Who cited this? | PubMed ID: 17145582 | Fulltext
Recommend
Mammalian target of rapamycin inhibitors in combination with letrozole in breast cancer.
+ cite this
+ View Abstract
Chollet P, Abrial C, Tacca O, Mouret-Reynier MA, Leheurteur M, Durando X, and Curé H
Clinical breast cancer 7(4):336-8, 2006 Oct - Who cited this? | PubMed ID: 17092402 | Fulltext
Recommend
Cystemustine in recurrent high grade glioma.
+ cite this
+ View Abstract
Durando X, Thivat E, Roché H, Bay JO, Lemaire JJ, Verrelle P, Chazal J, Curé H, and Chollet P
Journal of neuro-oncology 79(1):33-7, 2006 Aug - Who cited this? | PubMed ID: 16575534 | Fulltext
Recommend
Neoadjuvant endocrine therapy in breast cancer.
+ cite this
+ View Abstract
Abrial C, Mouret-Reynier MA, Curé H, Feillel V, Leheurteur M, Lemery S, Le Bouëdec G, Durando X, Dauplat J, and Chollet P
Breast (Edinburgh, Scotland) 15(1):9-19, 2006 Feb - Who cited this? | PubMed ID: 16230013 | Fulltext
Recommend
Does survival increase in metastatic breast cancer with recently available anticancer drugs?.
+ cite this
+ View Abstract
Abrial C, Leheurteur M, Cabrespine A, Mouret-Reynier MA, Durando X, Ferriere JP, Kwiatkowski F, Penault-Llorca F, Cure H, and Chollet P
Oncology research 15(9):431-9, 2006 - Who cited this? | PubMed ID: 16555549 | Fulltext
Recommend
Second-line chemotherapy of disseminated malignant melanoma with cystemustine at 60 mg/m2: a phase II trial.
+ cite this
+ View Abstract
Thivat E, Durando X, D'Incan M, Cure H, Mouret-Reynier MA, Madelmont JC, Souteyrand P, and Chollet P
Anti-cancer drugs 16(9):1003-7, 2005 Oct - Who cited this? | PubMed ID: 16162977 | Fulltext
Recommend
Long-term disease-free survival in advanced melanomas treated with nitrosoureas: mechanisms and new perspectives.
+ cite this
+ View Abstract
Durando X, Thivat E, D'Incan M, Sinsard A, Madelmont JC, and Chollet P
BMC cancer 5:147, 2005 - Who cited this? | PubMed ID: 16287507 | Fulltext
Recommend
[Management of a patient with cancer during all stages of the disease. Symptomatic treatment. Modalities of surveillance. Psychological, ethical and social problems].
+ cite this
Durando X and Curé H
La Revue du praticien 54(17):1949-55, 2004 Nov 15 - Who cited this? | PubMed ID: 15655922 | Fulltext
Recommend
Methionine dependency and cancer treatment.
+ cite this
+ View Abstract
Cellarier E, Durando X, Vasson MP, Farges MC, Demiden A, Maurizis JC, Madelmont JC, and Chollet P
Cancer treatment reviews 29(6):489-99, 2003 Dec - Who cited this? | PubMed ID: 14585259 | Fulltext
Recommend
[Prognostic value of epidermal growth factor receptor].
+ cite this
+ View Abstract
Penault-Llorca F, Durando X, and Bay JO
Bulletin du cancer 90 Spec No:S192-6, 2003 Nov - Who cited this? | PubMed ID: 14763139 | Fulltext
Recommend
High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients.
+ cite this
+ View Abstract
Durando X, Lemaire JJ, Tortochaux J, Van-Praagh I, Kwiatkowski F, Vincent C, Bailly C, Verrelle P, Irthum B, Chazal J, and Bay JO
Bone marrow transplantation 31(7):559-64, 2003 Apr - Who cited this? | PubMed ID: 12692621 | Fulltext
Recommend
Potential allogeneic graft-versus-tumor effect in a patient with ovarian cancer.
+ cite this
+ View Abstract
Bay JO, Choufi B, Pomel C, Dauplat J, Durando X, Tournilhac O, Travade P, Plagne R, and Blaise D
Bone marrow transplantation 25(6):681-2, 2000 Mar - Who cited this? | PubMed ID: 10734306 | Fulltext
Recommend



Search Google Scholar for Durando X

Join Labmeeting

  • Organize and search your PDF collection
  • Collect papers
  • Search millions of papers
  • Keep up to date with paper alerts
  • Read your papers from anywhere
  • Recommend papers to colleagues
  • Manage your lab
Sign Up

Join Labmeeting

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.


Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!